63 completed. 63 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 63 | Completed 63 |
| Phase 2 | 6 | Completed 6 |
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults Sonrotoclax Tablet for Oral Suspension, Sonrotoclax Tablet - Healthy Volunteers | Phase 1 | Completed | BeOne Medicines | 12 | 2026-06-17 | 2026-10-23 |
| A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults GS3-007a for Suspension, Placebo GS3-007a for Suspension - Healthy Adults | Phase 1 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 32 | 2026-01-07 | 2026-11-05 |
| Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions RLF-OD032 100 mg/mL oral suspension, Kuvan 100 MG Powder for Oral Solution - Bioequivalence | Phase 1 | Completed | APR Applied Pharma Research s.a. | 42 | 2025-08-20 | 2026-04-28 |
| A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension test formulation(T) 200 mg deuteriumremidvir hydrobromide for suspension, reference formulation(R) 100 mg deuteriumremidvir hydrobromide for suspension - Healthy Participants | Phase 1 | Completed | Vigonvita Life Sciences | 18 | 2025-08-11 | 2025-11-21 |
| Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation AQ280 Capsule, AQ280 Tablet for Oral Suspension, Placebo Capsule - Eosinophilic Esophagitis | Phase 1 | Completed | AQILION AB | 9 | 2025-06-13 | 2026-06-01 |
| Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ) Stiripentol capsule (Diacomit®), Stiripentol oral suspension (Diacomit®) - Dravet Syndrome, Epilepsy | Phase 1 | Completed | Biocodex | 24 | 2025-06-01 | 2025-09-16 |
| Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects GP681 tablet, GP681 Powder for Oral Suspension - Healthy Participants | Phase 1 | Completed | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 36 | 2024-09-27 | 2025-03-14 |
| A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg - Relative Bioavailability | Phase 1 | Completed | TrippBio, Inc. | 14 | 2024-09-01 | 2024-11-21 |
| Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets Bosentan Dispersible Tablets, Tracleer Tablet for Oral Suspension - Pulmonary Arterial Hypertension | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 32 | 2024-04-21 | 2024-07-03 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension Deuremidevir Hydrobromide for Suspension, Deuremidevir Hydrobromide for Suspension Placebo - Respiratory Syncytial Virus Infections | Phase 1 | Completed | Vigonvita Life Sciences | 24 | 2024-03-27 | 2024-10-01 |
| Bioequivalence Assessment Between Two Perampanel Oral Suspension Formulations Lepsiramp, 0.5 Mg/mL Oral Suspension, Fycompa, 0.5 Mg/mL Oral Suspension - Bioequivalence Study in Healthy Subjects | Phase 1 | Completed | Aya Mohammed Abdel Magid Abdel Hamid | 26 | 2024-03-07 | 2025-08-20 |
| A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension Deuremidevir Hydrobromide for Suspension 100mg, Deuremidevir Hydrobromide for Suspension 300mg, Deuremidevir Hydrobromide for Suspension 25mg - Healthy Subjects | Phase 1 | Completed | Vigonvita Life Sciences | 38 | 2023-07-09 | 2024-11-20 |
| Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Tetralogy of Fallot, Pulmonary Insufficiency | Phase 1 / Phase 2 | Completed | Nemours Children's Clinic | 25 | 2022-08-23 | 2026-04-27 |
| Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension Oseltamivir Phosphate For Oral Suspension/Tamiflu, Oseltamivir Phosphate For Oral Suspension - Healthy Subjects | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 72 | 2021-05-13 | 2022-03-28 |
| Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants Selitrectinib (BAY2731954) Adult tablet, Selitrectinib (BAY2731954) Pediatric tablet, Selitrectinib (BAY2731954) Oral solution - Solid Tumors Harboring NTRK Fusion | Phase 1 | Completed | Bayer | 52 | 2021-02-16 | 2021-08-25 |
| 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 EXS21546 Powder for Oral Suspension, EXS21546 Granule in Capsule, Midazolam - Oncology | Phase 1 | Completed | Exscientia AI Limited | 64 | 2020-12-08 | 2022-05-16 |
| An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects Tavapadon tablet, Tavapadon [14C] suspension - Healthy Subjects | Phase 1 | Completed | Cerevel Therapeutics, LLC | 12 | 2020-02-04 | 2020-11-17 |
| Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®) Azathioprine 50Mg Tab, Azathioprine 10mg/mL oral suspension - Therapeutic Equivalency | Phase 1 | Completed | Nova Laboratories Limited | 30 | 2019-04-11 | 2021-06-22 |
| India Dexamethasone and Betamethasone Dexamethasone 4 mg/ml, Betamethasone 4 mg/ml, Celestone Soluspan 6Mg/Ml Suspension for Injection - Preterm Birth, Antenatal Corticosteroids | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 48 | 2018-09-20 | 2020-07-14 |
| Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers Cefprozil 125mg/5ml Susp; Cefprozil granule (125mg) - Healthy Volunteers | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 60 | 2018-09-11 | 2020-06-04 |
Showing 20 of 63. Sign in to see all of them.
Bacterial Infections (2) · Epilepsy (2) · HIV Infections (2) · Neoplasms (2) · Pulmonary Arterial Hypertension (2) · Cystic Fibrosis (1) · Eosinophilic Esophagitis (1) · Epilepsies, Myoclonic (1) · Gram-Positive Bacterial Infections (1) · Heartburn (1) · Hepatitis C (1) · Infections (1) · Macular Degeneration (1) · Neoplasm Metastasis (1) · Neutropenia (1)
Teva Pharmaceuticals USA (6) · Bayer (5) · Sandoz (5) · Lakefront Biotherapeutics NV (3) · Vigonvita Life Sciences (3) · Actavis Inc. (2) · Aziende Chimiche Riunite Angelini Francesco S.p.A (2) · Janssen R&D Ireland (2) · Merck Sharp & Dohme LLC (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Nova Laboratories Limited (2) · Pfizer (2) · The Affiliated Hospital of Qingdao University (2) · APR Applied Pharma Research s.a. (1) · AQILION AB (1)
United States (17) · China (7) · United Kingdom (7) · Canada (5) · Belgium (4) · Brazil (4) · Germany (3) · South Africa (3) · Australia (2) · Botswana (2) · France (2) · India (2) · Jordan (2) · Netherlands (2) · Switzerland (2)
Magdy L. Shenouda, M.D. (2) · Milko Radicioni, MD (2) · Paul Y. Tam,, MD (2) · Soran Hong, M.D. (2) · Steven Herrmann, M.D. (2) · Xiaojie Wu (2) · Abdullah Hiyari, MD (1) · Alan Jobe, MD, Ph.D (1) · Andrew Wiznia, M.D. (1) · Andrew Wiznia, MD (1) · Anna Novotney-Barry (1)
PMID 24145879, PMID 29266308, PMID 30527329, PMID 31012984, PMID 31972249, PMID 32682946, PMID 33340343, PMID 33710976, PMID 34379314, PMID 34694878, PMID 34817414, PMID 35489377, PMID 36045513, PMID 37310224, PMID 38279383, PMID 40560938, PMID 41249688, PMID 42731017
2015 (4), 2014 (2), 2016 (1), 2017 (1), 2018 (1)